IRADIMED CORPORATION Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	86.28	83.81	73.24	65.56	53.3	41.81
Revenue Growth (YoY)	14.81%	14.43%	11.71%	23.00%	27.47%	31.84%
Cost of Revenue	19.99	19.49	16.89	15.4	12.02	9.76
Gross Profit	66.3	64.32	56.35	50.16	41.28	32.05
Selling, General & Admin	35.04	35.2	31.55	27.26	23.38	20.33
Research & Development	3.31	2.98	2.83	2.86	2.28	1.91
Total Operating Expenses	38.34	38.18	34.39	30.12	25.65	22.23
Operating Income	27.95	26.15	21.97	20.04	15.63	9.82
Total Non-Operating Income (Expense)	2.23	2.21	2.31	1.7	0.55	0.02
Pretax Income	30.18	28.36	24.28	21.74	16.18	9.84
Provision for Income Taxes	6.57	5.88	5.04	4.55	3.35	0.51
Net Income	23.61	22.48	19.23	17.19	12.83	9.33
Net Income to Common	23.61	22.48	19.23	17.19	12.83	9.33
Net Income Growth	19.34%	16.88%	11.87%	34.02%	37.56%	581.19%
Shares Outstanding (Basic)	13	13	13	13	13	12
Shares Outstanding (Diluted)	13	13	13	13	13	13
Shares Change (YoY)	0.52%	0.55%	0.48%	0.69%	0.36%	1.21%
EPS (Basic)	1.86	1.77	1.52	1.36	1.02	0.76
EPS (Diluted)	1.83	1.75	1.50	1.35	1.02	0.74
EPS Growth	18.07%	16.67%	11.11%	32.35%	37.84%	572.73%
Shares Outstanding	12.78	12.78	12.71	12.66	12.59	12.54
Free Cash Flow	24.47	17.18	17.62	6.02	9.22	10.78
Free Cash Flow Growth	42.44%	-2.48%	192.46%	-34.66%	-14.44%	100.50%
Free Cash Flow Per Share	1.90	1.34	1.38	0.47	0.73	0.86
Dividends Per Share	0.740	0.710	0.470	0.150	-	-
Dividend Growth	4.23%	51.06%	213.33%	-	-	-
Gross Margin	76.84%	76.75%	76.94%	76.50%	77.45%	76.65%
Operating Margin	32.40%	31.20%	29.99%	30.56%	29.32%	23.48%
Profit Margin	27.36%	26.82%	26.26%	26.22%	24.07%	22.30%
FCF Margin	28.37%	20.50%	24.06%	9.19%	17.30%	25.77%
EBITDA	29.38	27.31	22.78	20.8	16.3	11.22
EBITDA Margin	34.05%	32.59%	31.11%	31.73%	30.58%	26.84%
EBIT	27.95	26.15	21.97	20.04	15.63	9.82
EBIT Margin	32.40%	31.20%	29.99%	30.56%	29.32%	23.48%
Effective Tax Rate	21.78%	20.74%	20.77%	20.91%	20.72%	5.19%

SEC Filings: 10-K · 10-Q